The Ohio State University created the Center for Clinical and Translational Science (CCTS) to catalyze research teams and facilitate innovation through creation of an environment that fosters translation of knowledge to improve human health. The Center will accomplish four specific aims: 1) Build on the unique and diverse strengths of our institution to create an integrated academic home for innovative, team-oriented clinical and translational science;2) Enhance and nurture the career development of highly trained investigators, with an emphasis on innovation and transdisciplinary science;3) Integrate and enhance an administrative infrastructure to optimize the efficient conduct of the highest quality, generalizable clinical and translational science that is relevant to the community setting;4) Develop, enhance and integrate a portfolio of outstanding shared resources in support of transformative clinical and translational research. The CCTS will continue to focus on integrating the traditional biomedical research process (basic scientific discovery with translation to the bedside to dissemination into the community for improved patient outcomes) with a public health model (surveillance to prevention to response). By incorporating this bi-directional model in the creation of a robust translational science infrastructure, the OSU CCTS will foster both the traditional "discovery to best practice" paradigm as well as taking advantage of the insight garnered from our foundation of excellence in clinical care to stimulate basic discovery and clinical research inquiry. The vision and specific aims will be achieved through an integrated model of governance and partnership, home, and leadership for clinical and translational research spanning NCH and OSU;focused pilot funding initiatives for new team development within an innovation ecosystem;unique educational and training architecture which integrates acquisition of core competencies in research methodology, interpretation of results, implementation of findings, design thinking, team leadership skills and business acumen with rigorous discipline-specific laboratory (bench, clinical or community) training;and a clinical and translational science infrastructure that is cohesive, innovative.and adaptable and more effective than the services that currently exist in order to ensure provision of the full range of disease-agnostic scientific resources needed to traverse the continuum of research from T1-4.
The Center for Clinical and Translational Science will improve human health by bringing the benefits of science more quickly into patient care.
|Hartmann, Katherine; Seweryn, MichaÅ‚; Handleman, Samuel K et al. (2016) Non-linear interactions between candidate genes of myocardial infarction revealed in mRNA expression profiles. BMC Genomics 17:738|
|Xie, Nanzi; Li, Zhihong; Adesanya, Timothy M et al. (2016) Transplantation of placenta-derived mesenchymal stem cells enhances angiogenesis after ischemic limb injury in mice. J Cell Mol Med 20:29-37|
|Esber, Allahna; Rao, Nisha; Norris, Alison et al. (2016) Intravaginal Practices and Prevalence of Sexual and Reproductive Tract Infections Among Women in Rural Malawi. Sex Transm Dis 43:750-755|
|Borstad, Alexandra; Altenburger, Alex; Hannigan, Aaron et al. (2015) Design, Fabrication, and Administration of the Hand Active Sensation Test (HASTe). J Vis Exp :|
|Ma, Hanley; Liu, Jason; Bian, Zehua et al. (2015) Effect of metabolic syndrome on mitsugumin 53 expression and function. PLoS One 10:e0124128|
|Handelman, Samuel K; Seweryn, Michal; Smith, Ryan M et al. (2015) Conditional entropy in variation-adjusted windows detects selection signatures associated with expression quantitative trait loci (eQTLs). BMC Genomics 16 Suppl 8:S8|
|Horne, Tori E; VandeKopple, Matthew; Sauls, Kimberly et al. (2015) Dynamic Heterogeneity of the Heart Valve Interstitial Cell Population in Mitral Valve Health and Disease. J Cardiovasc Dev Dis 2:214-232|
|Zhao, Ning; Koenig, Sara N; Trask, Aaron J et al. (2015) MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells. Circ Res 116:23-34|
|Ansseau, EugÃ©nie; Domire, Jacqueline S; Wallace, Lindsay M et al. (2015) Aberrant splicing in transgenes containing introns, exons, and V5 epitopes: lessons from developing an FSHD mouse model expressing a D4Z4 repeat with flanking genomic sequences. PLoS One 10:e0118813|
|Lu, Rong; Smith, Ryan M; Seweryn, Michal et al. (2015) Analyzing allele specific RNA expression using mixture models. BMC Genomics 16:566|
Showing the most recent 10 out of 12 publications